Capricor Raises Nearly $2 Million
Los Angeles-based Capricor, a company developing stem cell therapies for treatment of cardiac disease, has raised roughly $2 million from Broadview Ventures and unnamed individual investors. Boston-based Broadview Ventures was formed by the Leducq Family Trust in 2008. The financing will allow Capricor to pursue clinical trials of its treatments.
20 December 2010•4 mins read
